← Back to Search

SCP Plus for Alzheimer's Dementia (SCP Plus Trial)

N/A
Waitlist Available
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
C. Family caregivers must self-identify as African American
E. Family caregivers must provide unpaid care for an older adult with ADRD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre, post, 6-month follow up
Awards & highlights

SCP Plus Trial Summary

This trial is testing a new psychoeducational intervention (The Senior Companion Program Plus, or SCP Plus) to help African American caregivers of people with Alzheimer's disease or related dementia. The intervention will be delivered by senior companions who are trained to provide the intervention in the homes of caregivers. The goal is to reduce caregiver burden and stress, and improve coping skills and satisfaction with support social.

Eligible Conditions
  • Alzheimer's Dementia
  • Family

SCP Plus Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
The family caregiver must be someone who identifies themselves as African American.
Select...
You are an unpaid family caregiver for an older adult with Alzheimer's or related dementia.

SCP Plus Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre, post, 6-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre, post, 6-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in caregiver burden and stress
Change in caregiver coping skills
Change in caregiver level of satisfaction with social support

SCP Plus Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SCP PlusExperimental Treatment1 Intervention
Group II: Services as usualActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SCP Plus
2019
N/A
~20

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor
42 Previous Clinical Trials
4,868 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,656 Previous Clinical Trials
28,004,180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots left for participants in this investigation?

"Evidently, this medical study is not enrolling patients at the present moment. Initially posted on May 16th 2019 and last updated October 27 of 2022, unfortunately there are no openings for participation in this trial. Fortunately though, 776 other clinical trials have vacancies open to prospective participants."

Answered by AI
~3 spots leftby Mar 2025